DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Yu ML, Hung CH, Cheng PN. et al.
Efficacy of 8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-Naive Chronic Hepatitis C Genotype 1b Patients with Mild Fibrosis: An Open-Label, Randomized, Active Control Trial (EGALITE)-Interim Report.
Hepatology 2018;
68: 595a-596a
We do not assume any responsibility for the contents of the web pages of other providers.